Danielle Savage
Internal Medicine · Rockaway, NJNPI 1891084083
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 214 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 35 manufacturers, the largest accounting for just 14.4% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2022 at $1,270 and has fallen 57.5% since, to $540 in 2023.
Across 214 payments — averaging $14.82 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Boehringer Ingelheim$458
- AbbVie$277
- Novo Nordisk$254
- Lilly USA, LLC$246
- Pfizer$210
- Otsuka America Pharmaceutical, Inc.$205
- plus $2K from 29 others
What the payments were for
- Food & beverage$3,172100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Boehringer Ingelheim | 30 | $458 |
| AbbVie | 22 | $277 |
| Novo Nordisk | 17 | $254 |
| Lilly USA, LLC | 16 | $246 |
| Pfizer | 14 | $210 |
| Otsuka America Pharmaceutical, Inc. | 11 | $205 |
| GSK | 13 | $178 |
| Merck | 12 | $172 |
| Takeda Pharmaceuticals U.S.A., Inc. | 11 | $148 |
| AstraZeneca | 10 | $132 |
| Amgen(2 entities) | 9 | $130 |
| Johnson & Johnson | 8 | $122 |
| Bayer | 4 | $81 |
| Abbott | 3 | $67 |
| Novartis | 5 | $65 |
| Axsome Therapeutics, Inc. | 3 | $48 |
| Mylan Specialty L.p. | 3 | $47 |
| Biohaven Pharmaceuticals, Inc. | 3 | $42 |
| Astellas Pharma US Inc | 3 | $39 |
| Amarin Pharma, Inc. | 2 | $28 |
| Neuronetics, Inc. | 1 | $26 |
| Althera Pharmaceuticals LLC | 1 | $19 |
| Cranial Technologies, Inc | 1 | $15 |
| Genentech USA, Inc. | 1 | $15 |
| Optinose US, Inc. | 1 | $15 |
| Biohaven Pharmaceutical Holding Company Ltd. | 1 | $15 |
| Eisai Inc. | 1 | $14 |
| Endo Pharmaceuticals Inc. | 1 | $14 |
| Bausch Health US, LLC | 1 | $14 |
| Kowa Pharmaceuticals America, Inc. | 1 | $14 |
| Arbor Pharmaceuticals, Inc. | 1 | $14 |
| Teva Pharmaceuticals USA, Inc. | 1 | $13 |
| Chiesi USA, Inc. | 1 | $13 |
| Shire North American Group Inc | 1 | $12 |
| Circassia Inc. | 1 | $11 |
How this compares
$3,172 in reported general payments places this provider in the 80th percentile of 4,032 internal medicine providers in New Jersey.
Other internal medicine in Rockaway
- David ShulkinMorristown$1.7M
- Howard UdermanLakewood$955K
- Darshi SunderamEast Orange$530K
- Annika DrongeEmerson$401K
- Stephen MarcellaNew Brunswick$331K
- Viju VijaysadanKinnelon$325K
- Mark MonaneWoodcliff Lake$268K
- Martin BedigianLivingston$240K
- Rameck HuntPlainsboro$217K
- Angel LazoSecaucus$195K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.